Navigation Links
DrugRisk Announces New Pradaxa Health Warning From Australia
Date:1/5/2013

Orlando, FL (PRWEB) January 05, 2013

The prescription drug resource center DrugRisk.com has added new information to its already comprehensive database for the blood thinner Pradaxa, after an Australian health advisory questioned whether the drug was safe enough for the government to supply it to citizens.

“DrugRisk’s goal is to improve patient safety through education with the latest drug warnings, recalls, studies and litigation news. Although most people never hear about drug warnings from other countries, these can be just as important as those in the U.S.,” explained DrugRisk representative Ryan Mayer.

Last month, Australia’s Pharmaceutical Benefits Advisory Committee (PBAC) warned that they may withdraw recommendations that the government continue to furnish prescriptions of Pradaxa.*

The Committee noted concerns that, while Pradaxa may have health and financial benefits over other anticoagulants, it may be prescribed for patients and at dosages not tested in clinical trials.

In the United States, experts disagree about the safety of Pradaxa bleeding risks. Last month the FDA updated warnings to say the drug carries the same risks as warfarin.** However, the New York Times also reported doctors’ concerns that Pradaxa led all medications for adverse reports and currently has no antidote for internal bleeding.***

Most common among the adverse reports were 6497 gastrointestinal side effects, 4910 gastrointestinal hemorrhages (bleeding) and 2941 central nervous system or cranial hemorrhaging problems. There were also 842 deaths attributed to the drug.****

Since September, the number of patients filing a Pradaxa lawsuit over internal bleeding has risen 50%.***** The cases have now been moved to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*pharmatimes.com/Article/12-12-20/Australia_warning_over_Pradaxa_PBS_listing.aspx
**fda.gov/Drugs/DrugSafety/ucm332912.htm***fda.gov/Drugs/DrugSafety/ucm326580.htm
***nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html
****adverseevents.com/drugdetail.php?AEDrugID=1067&BrandName=PRADAXA
*****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-internal/bleedings-risks/prweb10290093.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
2. DrugRisk Announces Updated Information on Mirena Lawsuits
3. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
4. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
5. The Life Support Technologies Group Announces 2013 Hyperbaric Medical Training Course Dates
6. Barton Associates Announces OB/GYN Locum Tenens Staffing Group
7. PCH Mutual Insurance CO., A RRG Announces Dividend for 2013
8. CoachingWebsites (Websites for Coaches) Announces a New Scheduling Calendar Feature for Coaches in 2013
9. Footwear etc. Announces the New Spring Collection from Orthaheel
10. Nutrisystem Announces Latest Weight Loss Success Story: Long Beach Husband and Wife Drop a Combined Total of 46 Pounds; Plus, Expert Dieting Tips for Couples
11. PMD Healthcare Announces how Spiro PD Personal Spirometer Supports New Year’s Resolution to Exercise and Lose Weight, Complementing ACAAI Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... April 24, 2017 , ... As part of the ... to honor the victims of the Holocaust and Nazi persecution, Center for Medicine ... and Auschwitz on its CMATH Champions trip to Germany and Poland next week. , ...
(Date:4/24/2017)... ... 2017 , ... The California Dental Association Foundation’s two-day volunteer dental clinic, ... during the April 22-23 event at the San Mateo Event Center. , In ... care, CDA Cares educates the public and policymakers about the importance of good oral ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, a company ... its popular products are now available for purchase on StackedNutrition.com, a popular website ... of premium natural ingredients in making all of its products. These ingredients come ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
Breaking Medicine Technology: